Media Coverage

The Analytical Challenges of the Biosimilar Boom


The biosimilar industry is growing. Mario DiPaola, Sr. Scientific Director at Charles River, breaks down the imbalance in the industry and why we could see some major changes in Contract Pharma.

David F Fischer on target screening


Drug Target Review editor Steve Bremer asks David F Fischer, Executive Director Biology at Charles River, for his views on target discovery and validation in drug discovery.

Biosimilars: Technical and Regulatory Challenges Featured Report


“Currently there isn’t a well-defined reimbursement framework for biosimilars. Unless this is addressed swiftly and correctly, it is likely to undermine the sustainability of this new market.” Read more from Mario DiPaola, Sr. Scientific Director at Charles River, in BioProcess International’s recent blog post.

Mouse Models Move Asian Markets


Asia is emerging as the next hot market for research animals. Now nearly half of the global market for mouse models is dominated by China, Singapore, Malaysia, and India. Terry Fisher of Charles River discusses with Lab Animal magazine.

Displaying results 1-10 (of 73)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8  >  >|